CARIATIDE (Compliance of ARomatase Inhibitors AssessmenT In Daily Practice Through Educational Approach)
Condition(s):Breast CancerLast Updated:January 18, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Breast CancerLast Updated:January 18, 2016Completed
Condition(s):Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast CancerLast Updated:September 6, 2019Completed
Condition(s):Breast NeoplasmsLast Updated:March 1, 2024Recruiting
Condition(s):Ovarian FollicleLast Updated:April 22, 2010Completed
Condition(s):HER2/Neu Negative; Invasive Breast Carcinoma; Postmenopausal; Stage 0 Breast Cancer; Stage IA Breast CancerLast Updated:December 27, 2018Withdrawn
Condition(s):Estrogen Receptor-positive Breast Cancer; HER2-negative Breast Cancer; Progesterone Receptor-positive Breast Cancer; Recurrent Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast CancerLast Updated:April 5, 2022Terminated
Condition(s):Liposarcoma; CRC; Prostate Cancer; Breast Neoplasms; Adenocarcinoma of Lung; Solid TumorsLast Updated:December 29, 2023Recruiting
Condition(s):Breast Cancer; Head and Neck CancerLast Updated:November 18, 2023Recruiting
Condition(s):Metastatic Breast CancerLast Updated:October 30, 2019Completed
Condition(s):Breast Cancer; Breast Cancer Female; HER2-positive Breast Cancer; Breast Cancer Stage II; Breast Cancer Stage IIILast Updated:March 7, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.